Vitamin B6 deficiency as a cause of polyneuropathy in POEMS syndrome: rapid recovery with supplementation in two cases.
Hajime YasudaYoshiki FurukawaKenya NishiokaMakoto SasakiYutaka TsukuneShuichi ShiraneNobutaka HattoriMiki AndoNorio KomatsuPublished in: Hematology (Amsterdam, Netherlands) (2022)
Objective physical improvement of POEMS-associated polyneuropathy has been reported to typically require approximately a year after autologous stem cell transplantation, and together with our observations of VB6 deficiency and supplementations leading to accelerated recoveries of polyneuropathy, VB6 deficiency most probably contributes to POEMS-associated polyneuropathy. VB6 acts as a coenzyme in approximately 150 biochemical reactions. VB6 has been reported to inhibit the hypoxia-inducible factor/vascular endothelial growth factor (VEGF) pathway, and VEGF levels are known to corollate with disease activity of POEMS syndrome. Therefore, VB6 deficiency may contribute not only to POEMS-associated polyneuropathy, but also to the etiology of POEMS syndrome itself.
Keyphrases
- vascular endothelial growth factor
- stem cell transplantation
- disease activity
- endothelial cells
- systemic lupus erythematosus
- rheumatoid arthritis
- replacement therapy
- case report
- ankylosing spondylitis
- rheumatoid arthritis patients
- bone marrow
- physical activity
- stem cells
- juvenile idiopathic arthritis
- cell therapy
- low dose
- mesenchymal stem cells
- platelet rich plasma
- smoking cessation